| Financial Year |
March 31 2022 |
| Monetary Funds |
590,632,926.04 |
| Held-for-trading Financial Assets |
1,834,800.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
414,466,088.02 |
| Advances to Suppliers |
171,635,996.64 |
| Other Receivables |
6,108,198.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
707,179,613.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
531,637,352.05 |
| Other Current Assets |
127,695,178.45 |
| Total Current Assets |
2,554,471,172.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
408,748,934.84 |
| Long-term Equity Investment |
423,645,954.78 |
| Investment Properties |
1,704,193,114.29 |
| Fixed Assetes |
1,127,490,698.61 |
| Under-construction Projects |
69,108,341.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
222,814,325.12 |
| R&D expenses |
-- |
| Goodwill |
14,428,555.49 |
| Long-Term Deferred and Prepaid Expenses |
33,896,461.09 |
| Deferred Income Tax Assets |
41,060,071.56 |
| Other Non-Current Assets |
122,267,385.71 |
| Sub-Total of Non-Current Assets |
4,169,333,764.17 |
| Total Assets |
6,723,804,936.67 |
| Short-Term Loans |
706,408,970.24 |
| Trading Financial liabilities |
-- |
| Notes Payable |
76,834,355.94 |
| Accounts Payable |
420,504,697.92 |
| Accounts Received In Advance |
4,746,996.18 |
| Employee Compensation Payable |
26,847,810.75 |
| Taxes Payable |
26,784,530.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
74,716,959.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
726,276,569.76 |
| Other Current Liabilities |
25,284,302.72 |
| Sub-Total of Current Liabilities |
2,314,626,657.51 |
| Long-term Loans |
1,278,743,227.21 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
139,781,744.44 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
124,059,295.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,592,652,102.53 |
| Total Liabilities |
3,907,278,760.04 |
| Paid-In Capital(Or Share Stock) |
423,387,356.00 |
| Capital Surplus |
2,262,332,886.74 |
| Surplus Reserve |
156,335,056.74 |
| LESS:Treasury Stock |
50,102,995.06 |
| Undistributed Profits |
-119,385,699.91 |
| Minority Stockholder's Interest |
96,811,429.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,719,714,747.13 |
| Owner's Equity（Stockholder's Equity） |
2,816,526,176.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,723,804,936.67 |
